 |
05-May-08: Insilicos Awarded Grant for Life Science Computing 03-Apr-08: Insilicos Wins NIH Grant for Manufacturing 14-Jan-08: Insilicos Heart Disease Project Wins Research Funding 30-Aug-07: Insilicos Awarded $1 Million Grant for Biotech Services 30-Apr-07: Insilicos Names Heinecke to Chief Medical Advisor Post 22-Sep-06: Insilicos and GeneBio Sign Global Distribution Agreement 29-May-06: Insilicos Announces Breakthrough Proteomics Software Platform 28-Mar-06: Insilicos Announces 1000th Licensed User of InsilicosViewer 13-Mar-06: Insilicos Awarded Grant to Study Heart Disease 14-Feb-06: Insilicos CEO Erik Nilsson Interviewed 06-Feb-06: Insilicos Awarded Grant to Commercialize Proteomics Research 14-Sep-05: Insilicos announces support for biotech data format 31-Aug-05: Insilicos Announces Web Support for Biotech Tools 08-Jul-05: Insilicos appoints Teresa Skarr as Director of Regulatory Affairs 04-Jun-05: Insilicos Announces 500th Licensed User of InsilicosViewer 27-Apr-05: Insilicos Presents at Invest Northwest 31-Mar-05: Insilicos releases new version of viewer 23-Feb-05: Insilicos Awarded Proteomics Grant 14-Dec-04: Ruedi Aebersold joins Insilicos Advisory Board 01-Sep-04: InsilicosViewer in the News 15-Apr-04: Insilicos Wins NIH Grant 13-Oct-03: Insilicos Releases Beta 26-Jun-03: Insilicos Wins Grant 30-Sep-02: Insilicos Platform Project Announced
| |
|
Ruedi Aebersold joins Insilicos Advisory Board
|
|
Seattle, 14 December 2004:
Biomedical software firm Insilicos today announced that proteomics pioneer Ruedi Aebersold has joined Insilicos' Scientific Advisory Board.
Prof. Aebersold is a prominent biologist, who has developed key proteomics techniques. He brings to the Advisory Board unique insights into molecular biology and proteomics.
Insilicos' Scientific Advisory Board represents a deep and formidable understanding of modern biological research. Each member has made important contributions to the advance of biotech.
"These scientists have achieved ground-breaking research in systems biology, analytical chemistry, and other areas of science," said Insilicos Chief Scientist Dr. Bryan Prazen. "Our research program benefits from their experience and cutting-edge insight."
"We welcome Professor Aebersold to the Board," said Insilicos President Erik Nilsson. "It's an honor to have such an outstanding group of individuals on our Scientific Advisory Board. These very busy researchers view Insilicos as a good investment of their time. That's a gratifying vote of confidence in our approach."
The Board comprises:
Ruedi Aebersold, Professor of Systems Biology, Institute of Biotechnology, Swiss Federal Institute of Technology, Zürich.
Norman Dovichi, Endowed Professor of Analytical Chemistry, University of Washington.
David Robinson Goodlett, Associate Professor, Department of Medicinal Chemistry, University of Washington.
Nels Olson, Senior Staff Scientist and Associate Director, Illumina, Inc.
Robert Synovec, Professor of Chemistry, University of Washington.
More information on Insilicos' Advisory Board can be found at www.insilicos.com/about.htmlInsilicos LLC develops life science software for pharmaceutical development, biological research and clinical diagnostics.
For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' and 'Life Science Software' are trademarks of Insilicos LLC.
|
|
